drugset / Trial / NCT00857857

A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics

NCT00857857

Phase 2 Completed 24 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

The study will measure the early and late asthamtic response using an allergen challenge. This study will evaluate the safety and patients tolerance to repeat inhaled doses of GW870086X using a number of clinical and biological markers.

Timeline

Start
2009-02-16
Primary completion
2009-11-03
Completion
2009-11-03

Publications

  • Background Bareille P, Allen A, Hardes K, Donald A. Effect of repeat inhaled doses of GW870086 on the allergen-induced early and late asthmatic response in subjects with mild asthma. Curr Drug Ther. 2013;8(2)

Drugs

EvaluationDrugModalityDoseRoute
Subject FP Unknown
Subject GW870086 Small molecule

Indications